-
Dec 19, 2018 | 16:04 pm
Read more...
-
Nov 3, 2017 | 09:30 am
A two-drug combination therapy for cystic fibrosis is shown to be effective. Triple combination therapy is close behind.
Read more...
-
May 15, 2017 | 08:30 am
Successful Phase III trials at UAB contributed to the development of a novel “corrector-potentiator” combination drug therapy for cystic fibrosis patients.
Read more...
-
Oct 4, 2016 | 15:00 pm
UAB and UMass researchers have uncovered a new mechanistic understanding of potential treatment for genetic disorders.
Read more...
-
May 25, 2016 | 08:00 am
Cystic fibrosis lung cells were restored to 50 percent of healthy function in work that provides the first evidence that novel therapeutic strategies for human patients can be identified based on yeast studies.
Read more...
-
Oct 22, 2015 | 12:45 pm
Southern Research and UAB launch a search for compounds that might provide new therapies for CF nonsense mutations.
Read more...